CXCL13 and myeloid sarcoma: Each additional year of the onset age of MS corresponded to a 1.135 pg/mL increase in CXCL13 (p = 0.012), and each one-unit increase in EDSS was associated with a 22.003 pg/mL increase in CXCL13 (p < 0.001).